This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Viscidi, R. P.
Right arrow Articles by Shah, K. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Viscidi, R. P.
Right arrow Articles by Shah, K. V.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, Mar 1997, 122-126, Vol 4, No. 2
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Prevalence of antibodies to human papillomavirus (HPV) type 16 virus- like particles in relation to cervical HPV infection among college women

RP Viscidi, KL Kotloff, B Clayman, K Russ, S Shapiro and KV Shah
Eudowood Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. rviscidi@welchlink.welch.jhu.edu

A human papillomavirus type 16 (HPV-16) virus-like particle (VLP)-based enzyme-linked immunosorbent assay (ELISA) was used to measure serum antibody to capsid proteins in 376 sexually active college women who were also screened for the presence of genital HPVs by PCR and interviewed for demographic and behavioral risk factors for HPV infection. The seroprevalence was 46% in women with HPV-16 DNA in the genital tract. The corresponding values for women who harbored other HPV types or no HPV in the genital tract were 30 and 19%, respectively (HPV-16 group versus no-HPV group; odds ratio [OR], 3.7; 95% confidence interval [CI], 1.5 to 8.9). The antibody response was significantly higher among women with a high viral load than among those with a low viral load (median optical density value, 0.838 versus 0.137, P = 0.009). Comparable levels of seroreactivity were observed among women infected with HPV types distantly or closely related genetically to HPV- 16. Seroreactivity was significantly associated with an age of 25 to 30 years (OR, 2.3; 95% CI, 1.2 to 4.4), three or more lifetime sexual partners (OR, 2.9; 95% CI, 1.1 to 10), and history of a sexually transmitted disease other than HPV (OR, 3.1; 95% CI, 1.5 to 6.3). The percent seropositivity increased linearly with number of lifetime sexual partners until reaching a plateau at 35% for women with more than six partners (chi for linear trend, P < 0.001). The low sensitivity of HPV-16 VLP-based ELISA may limit the usefulness of the assay as a diagnostic test for HPV-16 infection. However, the assay appears to have adequate specificity and should be useful as an epidemiological marker of HPV-16 infection and sexual behavior.


This article has been cited by other articles:

  • Viscidi, R. P., Snyder, B., Cu-Uvin, S., Hogan, J. W., Clayman, B., Klein, R. S., Sobel, J., Shah, K. V. (2005). Human Papillomavirus Capsid Antibody Response to Natural Infection and Risk of Subsequent HPV Infection in HIV-Positive and HIV-Negative Women. Cancer Epidemiol. Biomarkers Prev. 14: 283-288 [Abstract] [Full Text]  
  • Viscidi, R. P., Schiffman, M., Hildesheim, A., Herrero, R., Castle, P. E., Bratti, M. C., Rodriguez, A. C., Sherman, M. E., Wang, S., Clayman, B., Burk, R. D. (2004). Seroreactivity to Human Papillomavirus (HPV) Types 16, 18, or 31 and Risk of Subsequent HPV Infection: Results from a Population-Based Study in Costa Rica. Cancer Epidemiol. Biomarkers Prev. 13: 324-327 [Abstract] [Full Text]  
  • Ho, G. Y. F., Studentsov, Y. Y., Bierman, R., Burk, R. D. (2004). Natural History of Human Papillomavirus Type 16 Virus-Like Particle Antibodies in Young Women. Cancer Epidemiol. Biomarkers Prev. 13: 110-116 [Abstract] [Full Text]  
  • Studentsov, Y. Y., Ho, G. Y. F., Marks, M. A., Bierman, R., Burk, R. D. (2003). Polymer-Based Enzyme-Linked Immunosorbent Assay Using Human Papillomavirus Type 16 (HPV16) Virus-Like Particles Detects HPV16 Clade-Specific Serologic Responses. J. Clin. Microbiol. 41: 2827-2834 [Abstract] [Full Text]  
  • Iftner, T., Villa, L. L. (2003). Chapter 12: Human Papillomavirus Technologies. J Natl Cancer Inst Monogr 2003: 80-88 [Abstract] [Full Text]  
  • Cameron, J. E., Snowhite, I. V., Chaturvedi, A. K., Hagensee, M. E. (2003). Human Papillomavirus-Specific Antibody Status in Oral Fluids Modestly Reflects Serum Status in Human Immunodeficiency Virus-Positive Individuals. CVI 10: 431-438 [Abstract] [Full Text]  
  • Viscidi, R. P., Rollison, D. E. M., Viscidi, E., Clayman, B., Rubalcaba, E., Daniel, R., Major, E. O., Shah, K. V. (2003). Serological Cross-Reactivities between Antibodies to Simian Virus 40, BK Virus, and JC Virus Assessed by Virus-Like-Particle-Based Enzyme Immunoassays. CVI 10: 278-285 [Abstract] [Full Text]  
  • Nakagawa, M., Viscidi, R., Deshmukh, I., Costa, M. D., Palefsky, J. M., Farhat, S., Moscicki, A.-B. (2002). Time Course of Humoral and Cell-Mediated Immune Responses to Human Papillomavirus Type 16 in Infected Women. CVI 9: 877-882 [Abstract] [Full Text]  
  • Karem, K. L., Poon, A. C., Bierl, C., Nisenbaum, R., Unger, E. (2002). Optimization of a Human Papillomavirus-Specific Enzyme-Linked Immunosorbent Assay. CVI 9: 577-582 [Abstract] [Full Text]  
  • Touze, A., de Sanjose, S., Coursaget, P., Almirall, M. R., Palacio, V., Meijer, C. J. L. M., Kornegay, J., Bosch, F. X. (2001). Prevalence of Anti-Human Papillomavirus Type 16, 18, 31, and 58 Virus-Like Particles in Women in the General Population and in Prostitutes. J. Clin. Microbiol. 39: 4344-4348 [Abstract] [Full Text]  
  • Buka, S. L., Tsuang, M. T., Torrey, E. F., Klebanoff, M. A., Bernstein, D., Yolken, R. H. (2001). Maternal Infections and Subsequent Psychosis Among Offspring. Arch Gen Psychiatry 58: 1032-1037 [Abstract] [Full Text]  
  • Sun, Y., Eluf-Neto, J., Bosch, F. X., Muñoz, N., Walboomers, J. M. M., Meijer, C. J. L. M., Shah, K. V., Clayman, B., Viscidi, R. P. (1999). Serum Antibodies to Human Papillomavirus 16 Proteins in Women from Brazil with Invasive Cervical Carcinoma. Cancer Epidemiol. Biomarkers Prev. 8: 935-940 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»